First Mining Gold Corp. (FFMGF)

Verve Therapeutics Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Selling, General & Admin	5.29	5.46	5.99	5.38	5.65	4.04
Other Operating Expenses	13.46	0.12	7.12	1.06	3.05	5.88
Operating Expenses	19.74	6.62	14.02	7.23	9.93	20.12
Operating Income	-19.74	-6.62	-14.02	-7.23	-9.93	-20.12
Interest & Investment Income	0.95	1.18	0.94	0.26	0.42	0.18
Earnings From Equity Investments	1.22	0.61	-1.54	-0.99	-5.86	1.45
Currency Exchange Gain (Loss)	0.19	0.26	-0.13	0.04	-0.1	0.33
Other Non Operating Income (Expenses)	-0.73	-0.82	0.4	-2.43	-2.08	-1.08
EBT Excluding Unusual Items	-18.11	-5.39	-14.35	-10.35	-17.55	-19.24
Gain (Loss) on Sale of Investments	11.98	-0.01	-1.55	-10.56	-28.51	-14.87
Gain (Loss) on Sale of Assets	-	-	7.28	5.73	8.83	-0.3
Asset Writedown	-11.96	-11.96	-	-1.4	-	-
Legal Settlements	-	-	-	-	-1.12	-
Pretax Income	-18.09	-17.36	-8.61	-16.59	-38.35	-34.4
Income Tax Expense	-1.99	-2.05	-1.58	-0.31	-	-1.59
Net Income	-16.1	-15.31	-7.04	-16.28	-38.35	-32.82
Net Income to Common	-16.1	-15.31	-7.04	-16.28	-38.35	-32.82
Shares Outstanding (Basic)	1,012	972	827	738	699	645
Shares Outstanding (Diluted)	1,012	976	827	738	699	645
Shares Change (YoY)	18.38%	17.99%	12.03%	5.66%	8.33%	12.19%
EPS (Basic)	-0.02	-0.02	-0.01	-0.02	-0.05	-0.05
EPS (Diluted)	-0.02	-0.02	-0.01	-0.02	-0.05	-0.05
Free Cash Flow	-27.73	-25.05	-23.61	-30.8	-22.92	-22.12
Free Cash Flow Per Share	-0.03	-0.03	-0.03	-0.04	-0.03	-0.03
EBITDA	-19.26	-6.14	-13.54	-6.82	-9.61	-10.57
D&A For EBITDA	0.48	0.49	0.48	0.41	0.32	9.54
EBIT	-19.74	-6.62	-14.02	-7.23	-9.93	-20.12

Source: S&P Global Market Intelligence. Standard template. Financial Sources.